Super. was bullish by reading their annual report 1 year back. brought at 280 then share went down to 180 then back and doubled now. 1 year back pharma was hated sector. seems now people are interested.
Disc – Invest and being like a sleeping partner to see their 1000 crore revenue target for 2027
| Subscribe To Our Free Newsletter |
